Shikoku Medical Center for Children and Adults
Zentsujichó 765-8507
2 studies enrolling now · 3 studies all time
What they study most
Obesity, Overweight, Respiratory Syncytial Viruses
Studies at this site
- A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities — Recruiting now
- A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) — Recruiting now
- A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial Virus — Stopped early